Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
January 6, 2019
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
Ralf Schirrmacher, Justin J Bailey, Andrew V Mossine, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
Lena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2020
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
Christian Sacher, Tanja Blume, Leonie Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 29, 2018
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice
Carola Focke, Tanja Blume, Benedikt Zott, et al.
Journal of Neuroinflammation
|
July 15, 2020
Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
Florian Eckenweber, Jose Medina-Luque, Tanja Blume, et al.
Research Square
|
February 26, 2026
Non-compacted, PET-insensitive amyloid states increase after systemic inflammation and predict neuritic damage across Aβ pathology models and Alzheimer patients
Jonas Neher, Ping Liu, Ann-Christin Wendeln, et al.
Annals of Clinical and Translational Neurology
|
March 25, 2026
[<sup>18</sup>F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis
Julia S Dorneich, Jonathan A Gernert, Hanna Zimmermann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2021
Dosimetry and optimal scan time of [<sup>18</sup>F]SiTATE-PET/CT in patients with neuroendocrine tumours
Leonie Beyer, Astrid Gosewisch, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2023
Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATE
Marcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Endocrine Oncology (Bristol, England)
|
October 23, 2025
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
Katharina Wang, Christoph J Auernhammer, Simon Lindner, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
Pharmaceuticals (Basel, Switzerland)
|
January 6, 2019
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
Ralf Schirrmacher, Justin J Bailey, Andrew V Mossine, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
Lena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2020
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
Christian Sacher, Tanja Blume, Leonie Beyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 29, 2018
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice
Carola Focke, Tanja Blume, Benedikt Zott, et al.
Journal of Neuroinflammation
|
July 15, 2020
Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
Florian Eckenweber, Jose Medina-Luque, Tanja Blume, et al.
Research Square
|
February 26, 2026
Non-compacted, PET-insensitive amyloid states increase after systemic inflammation and predict neuritic damage across Aβ pathology models and Alzheimer patients
Jonas Neher, Ping Liu, Ann-Christin Wendeln, et al.
Annals of Clinical and Translational Neurology
|
March 25, 2026
[<sup>18</sup>F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis
Julia S Dorneich, Jonathan A Gernert, Hanna Zimmermann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2021
Dosimetry and optimal scan time of [<sup>18</sup>F]SiTATE-PET/CT in patients with neuroendocrine tumours
Leonie Beyer, Astrid Gosewisch, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2023
Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATE
Marcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Endocrine Oncology (Bristol, England)
|
October 23, 2025
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
Katharina Wang, Christoph J Auernhammer, Simon Lindner, et al.
Page
of 13